NVAX logo

Novavax, Inc. (NVAX) EBIT

Annual EBIT:

-$231.97M+$183.06M(+44.11%)
December 31, 2024

Summary

  • As of today, NVAX annual earnings before interest & taxes is -$231.97 million, with the most recent change of +$183.06 million (+44.11%) on December 31, 2024.
  • During the last 3 years, NVAX annual EBIT has risen by +$1.45 billion (+86.25%).
  • NVAX annual EBIT is now -4980.38% below its all-time high of -$4.57 million, reached on December 31, 1999.

Performance

NVAX EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVAXincome statement metrics

Quarterly EBIT:

-$79.40M-$185.07M(-175.14%)
September 30, 2025

Summary

  • As of today, NVAX quarterly earnings before interest & taxes is -$79.40 million, with the most recent change of -$185.07 million (-175.14%) on September 30, 2025.
  • Over the past year, NVAX quarterly EBIT has increased by +$50.37 million (+38.81%).
  • NVAX quarterly EBIT is now -115.39% below its all-time high of $516.02 million, reached on March 31, 2025.

Performance

NVAX Quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVAXincome statement metrics

TTM EBIT:

$416.73M+$50.37M(+13.75%)
September 30, 2025

Summary

  • As of today, NVAX TTM earnings before interest & taxes is $416.73 million, with the most recent change of +$50.37 million (+13.75%) on September 30, 2025.
  • Over the past year, NVAX TTM EBIT has increased by +$706.69 million (+243.72%).
  • NVAX TTM EBIT is now -1.44% below its all-time high of $422.81 million, reached on March 31, 2025.

Performance

NVAX TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherNVAXincome statement metrics

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

NVAX EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+44.1%+38.8%+243.7%
3Y3 Years+86.3%+37.6%+134.0%
5Y5 Years-79.0%+58.9%+260.3%

NVAX EBIT Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+86.3%-115.4%+74.6%-1.4%+134.0%
5Y5-Year-79.0%+86.3%-115.4%+90.4%-1.4%+124.7%
All-TimeAll-Time-4980.4%+86.3%-115.4%+90.4%-1.4%+124.7%

NVAX EBIT History

DateAnnualQuarterlyTTM
Sep 2025
-
-$79.40M(-175.1%)
$416.73M(+13.7%)
Jun 2025
-
$105.67M(-79.5%)
$366.36M(-13.4%)
Mar 2025
-
$516.02M(+511.0%)
$422.81M(+282.3%)
Dec 2024
-$231.97M(+44.1%)
-$125.55M(+3.3%)
-$231.94M(+20.0%)
Sep 2024
-
-$129.77M(-180.0%)
-$289.95M(-1.4%)
Jun 2024
-
$162.12M(+216.9%)
-$285.95M(+24.3%)
Mar 2024
-
-$138.73M(+24.4%)
-$377.89M(+31.5%)
Dec 2023
-$415.03M(+35.6%)
-$183.57M(-46.0%)
-$551.93M(+9.9%)
Sep 2023
-
-$125.77M(-279.2%)
-$612.24M(+0.2%)
Jun 2023
-
$70.18M(+122.4%)
-$613.65M(+47.4%)
Mar 2023
-
-$312.77M(-28.2%)
-$1.17B(-81.0%)
Dec 2022
-$644.74M(+61.8%)
-$243.88M(-91.7%)
-$644.74M(+47.4%)
Sep 2022
-
-$127.19M(+73.7%)
-$1.23B(+12.8%)
Jun 2022
-
-$482.96M(-330.8%)
-$1.41B(-10.8%)
Mar 2022
-
$209.29M(+125.4%)
-$1.27B(+24.8%)
Dec 2021
-$1.69B(-307.4%)
-$824.97M(-168.6%)
-$1.69B(-61.5%)
Sep 2021
-
-$307.14M(+11.2%)
-$1.04B(-12.2%)
Jun 2021
-
-$345.83M(-65.8%)
-$930.56M(-55.1%)
Mar 2021
-
-$208.63M(-14.1%)
-$599.85M(-44.9%)
Dec 2020
-$414.02M(-219.5%)
-$182.85M(+5.4%)
-$414.12M(-59.3%)
Sep 2020
-
-$193.24M(-1177.5%)
-$259.97M(-186.5%)
Jun 2020
-
-$15.13M(+33.9%)
-$90.73M(+19.2%)
Mar 2020
-
-$22.90M(+20.2%)
-$112.27M(+13.4%)
Dec 2019
-$129.60M(+25.5%)
-$28.70M(-19.6%)
-$129.60M(+12.1%)
Sep 2019
-
-$24.00M(+34.5%)
-$147.40M(+10.8%)
Jun 2019
-
-$36.67M(+8.8%)
-$165.30M(+3.1%)
Mar 2019
-
-$40.22M(+13.5%)
-$170.63M(+1.9%)
Dec 2018
-$173.92M(-1.3%)
-$46.51M(-11.0%)
-$173.92M(+0.7%)
Sep 2018
-
-$41.90M(+0.2%)
-$175.19M(-0.2%)
Jun 2018
-
-$41.99M(+3.5%)
-$174.92M(-0.3%)
Mar 2018
-
-$43.51M(+8.9%)
-$174.40M(-1.6%)
Dec 2017
-$171.71M(+36.2%)
-$47.78M(-14.8%)
-$171.71M(+3.5%)
Sep 2017
-
-$41.63M(-0.4%)
-$177.97M(+10.9%)
Jun 2017
-
-$41.47M(-1.6%)
-$199.65M(+14.9%)
Mar 2017
-
-$40.83M(+24.5%)
-$234.68M(+12.8%)
Dec 2016
-$269.11M(-71.2%)
-$54.05M(+14.6%)
-$269.11M(+8.5%)
Sep 2016
-
-$63.31M(+17.2%)
-$293.97M(-11.4%)
Jun 2016
-
-$76.50M(-1.6%)
-$263.86M(-26.7%)
Mar 2016
-
-$75.26M(+4.6%)
-$208.18M(-32.4%)
Dec 2015
-$157.24M(-87.9%)
-$78.90M(-137.7%)
-$157.24M(-42.9%)
Sep 2015
-
-$33.20M(-59.4%)
-$110.00M(-13.9%)
Jun 2015
-
-$20.82M(+14.4%)
-$96.59M(-3.2%)
Mar 2015
-
-$24.31M(+23.2%)
-$93.62M(-11.9%)
Dec 2014
-$83.69M(-63.7%)
-$31.66M(-60.0%)
-$83.69M(-26.3%)
Sep 2014
-
-$19.79M(-10.9%)
-$66.28M(-9.6%)
Jun 2014
-
-$17.85M(-24.1%)
-$60.47M(-8.9%)
Mar 2014
-
-$14.38M(-0.9%)
-$55.52M(-8.6%)
Dec 2013
-$51.13M(-72.4%)
-$14.25M(-2.0%)
-$51.13M(-10.3%)
Sep 2013
-
-$13.98M(-8.4%)
-$46.38M(-18.2%)
Jun 2013
-
-$12.90M(-28.9%)
-$39.25M(-21.9%)
Mar 2013
-
-$10.01M(-5.4%)
-$32.20M(-8.6%)
Dec 2012
-$29.66M(-37.5%)
-$9.49M(-38.6%)
-$29.67M(-21.4%)
Sep 2012
-
-$6.85M(-17.0%)
-$24.43M(-13.4%)
Jun 2012
-
-$5.86M(+21.6%)
-$21.55M(+0.3%)
Mar 2012
-
-$7.47M(-75.3%)
-$21.61M(-0.2%)
Dec 2011
-$21.58M(+43.9%)
-$4.26M(-7.3%)
-$21.58M(+11.4%)
Sep 2011
-
-$3.97M(+33.0%)
-$24.35M(+21.2%)
Jun 2011
-
-$5.92M(+20.3%)
-$30.92M(+10.3%)
Mar 2011
-
-$7.43M(-5.6%)
-$34.47M(+10.5%)
Dec 2010
-$38.49M
-$7.03M(+33.3%)
-$38.49M(+15.6%)
DateAnnualQuarterlyTTM
Sep 2010
-
-$10.54M(-11.3%)
-$45.62M(-5.3%)
Jun 2010
-
-$9.47M(+17.3%)
-$43.34M(-3.9%)
Mar 2010
-
-$11.45M(+19.1%)
-$41.70M(-11.5%)
Dec 2009
-$37.38M(-8.8%)
-$14.15M(-71.3%)
-$37.38M(-15.2%)
Sep 2009
-
-$8.26M(-5.5%)
-$32.44M(+4.3%)
Jun 2009
-
-$7.83M(-9.7%)
-$33.90M(+1.1%)
Mar 2009
-
-$7.14M(+22.5%)
-$34.28M(+0.2%)
Dec 2008
-$34.36M(-13.5%)
-$9.21M(+5.3%)
-$34.36M(-7.9%)
Sep 2008
-
-$9.73M(-18.6%)
-$31.85M(-1.5%)
Jun 2008
-
-$8.20M(-13.6%)
-$31.38M(+1.6%)
Mar 2008
-
-$7.22M(-7.8%)
-$31.90M(+5.3%)
Dec 2007
-$30.27M(-23.0%)
-$6.70M(+27.6%)
-$33.67M(+7.9%)
Sep 2007
-
-$9.26M(-6.1%)
-$36.57M(-10.8%)
Jun 2007
-
-$8.72M(+3.0%)
-$33.01M(-5.4%)
Mar 2007
-
-$8.99M(+6.3%)
-$31.32M(-14.5%)
Dec 2006
-$24.61M(-25.6%)
-$9.60M(-68.6%)
-$27.37M(-29.3%)
Sep 2006
-
-$5.69M(+19.1%)
-$21.17M(-14.0%)
Jun 2006
-
-$7.04M(-39.8%)
-$18.57M(-10.8%)
Mar 2006
-
-$5.04M(-48.0%)
-$16.75M(+16.8%)
Dec 2005
-$19.59M(+43.9%)
-$3.40M(-10.0%)
-$20.14M(+24.4%)
Sep 2005
-
-$3.09M(+40.8%)
-$26.64M(+23.9%)
Jun 2005
-
-$5.22M(+37.9%)
-$35.02M(+5.7%)
Mar 2005
-
-$8.42M(+15.0%)
-$37.14M(-10.5%)
Dec 2004
-$34.90M(-117.4%)
-$9.91M(+13.7%)
-$33.62M(-25.6%)
Sep 2004
-
-$11.48M(-56.3%)
-$26.77M(-46.6%)
Jun 2004
-
-$7.34M(-49.9%)
-$18.26M(-17.4%)
Mar 2004
-
-$4.90M(-60.0%)
-$15.55M(+3.1%)
Dec 2003
-$16.05M(+25.5%)
-$3.06M(-3.4%)
-$16.05M(+10.2%)
Sep 2003
-
-$2.96M(+36.1%)
-$17.89M(+15.9%)
Jun 2003
-
-$4.63M(+14.2%)
-$21.26M(+2.8%)
Mar 2003
-
-$5.40M(-10.4%)
-$21.87M(-1.4%)
Dec 2002
-$21.56M(-61.1%)
-$4.89M(+22.8%)
-$21.56M(+9.6%)
Sep 2002
-
-$6.34M(-21.1%)
-$23.84M(-20.0%)
Jun 2002
-
-$5.23M(-2.7%)
-$19.87M(-21.8%)
Mar 2002
-
-$5.09M(+29.0%)
-$16.32M(-22.0%)
Dec 2001
-$13.38M(-5.0%)
-$7.17M(-202.4%)
-$13.38M(-18.5%)
Sep 2001
-
-$2.37M(-41.0%)
-$11.29M(+8.2%)
Jun 2001
-
-$1.68M(+21.9%)
-$12.29M(+8.5%)
Mar 2001
-
-$2.15M(+57.7%)
-$13.44M(-5.5%)
Dec 2000
-$12.74M(-179.1%)
-$5.08M(-50.6%)
-$12.74M(-47.4%)
Sep 2000
-
-$3.38M(-19.4%)
-$8.65M(-22.6%)
Jun 2000
-
-$2.83M(-94.3%)
-$7.05M(-37.4%)
Mar 2000
-
-$1.46M(-47.3%)
-$5.13M(-12.4%)
Dec 1999
-$4.57M(+11.4%)
-$988.00K(+44.6%)
-$4.57M(+12.9%)
Sep 1999
-
-$1.78M(-96.8%)
-$5.24M(-10.5%)
Jun 1999
-
-$906.00K(-1.9%)
-$4.74M(+7.3%)
Mar 1999
-
-$889.00K(+46.5%)
-$5.11M(+0.7%)
Dec 1998
-$5.15M(-7.5%)
-$1.66M(-29.2%)
-$5.15M(-12.2%)
Sep 1998
-
-$1.29M(-0.6%)
-$4.59M(-1.9%)
Jun 1998
-
-$1.28M(-37.9%)
-$4.50M(+0.5%)
Mar 1998
-
-$926.60K(+15.8%)
-$4.53M(+3.7%)
Dec 1997
-$4.79M(+13.4%)
-$1.10M(+8.3%)
-$4.70M(+13.0%)
Sep 1997
-
-$1.20M(+7.7%)
-$5.40M(-3.8%)
Jun 1997
-
-$1.30M(-18.2%)
-$5.20M(0.0%)
Mar 1997
-
-$1.10M(+38.9%)
-$5.20M(0.0%)
Dec 1996
-$5.53M(+17.9%)
-$1.80M(-80.0%)
-$5.20M(-52.9%)
Sep 1996
-
-$1.00M(+23.1%)
-$3.40M(-41.7%)
Jun 1996
-
-$1.30M(-18.2%)
-$2.40M(-118.2%)
Mar 1996
-
-$1.10M
-$1.10M
Dec 1995
-$6.74M
-
-

FAQ

  • What is Novavax, Inc. annual earnings before interest & taxes?
  • What is the all-time high annual EBIT for Novavax, Inc.?
  • What is Novavax, Inc. annual EBIT year-on-year change?
  • What is Novavax, Inc. quarterly earnings before interest & taxes?
  • What is the all-time high quarterly EBIT for Novavax, Inc.?
  • What is Novavax, Inc. quarterly EBIT year-on-year change?
  • What is Novavax, Inc. TTM earnings before interest & taxes?
  • What is the all-time high TTM EBIT for Novavax, Inc.?
  • What is Novavax, Inc. TTM EBIT year-on-year change?

What is Novavax, Inc. annual earnings before interest & taxes?

The current annual EBIT of NVAX is -$231.97M

What is the all-time high annual EBIT for Novavax, Inc.?

Novavax, Inc. all-time high annual earnings before interest & taxes is -$4.57M

What is Novavax, Inc. annual EBIT year-on-year change?

Over the past year, NVAX annual earnings before interest & taxes has changed by +$183.06M (+44.11%)

What is Novavax, Inc. quarterly earnings before interest & taxes?

The current quarterly EBIT of NVAX is -$79.40M

What is the all-time high quarterly EBIT for Novavax, Inc.?

Novavax, Inc. all-time high quarterly earnings before interest & taxes is $516.02M

What is Novavax, Inc. quarterly EBIT year-on-year change?

Over the past year, NVAX quarterly earnings before interest & taxes has changed by +$50.37M (+38.81%)

What is Novavax, Inc. TTM earnings before interest & taxes?

The current TTM EBIT of NVAX is $416.73M

What is the all-time high TTM EBIT for Novavax, Inc.?

Novavax, Inc. all-time high TTM earnings before interest & taxes is $422.81M

What is Novavax, Inc. TTM EBIT year-on-year change?

Over the past year, NVAX TTM earnings before interest & taxes has changed by +$706.69M (+243.72%)
On this page